ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Private equity firm Edgewater Capital Partners, based in Cleveland, has acquired GL Chemtec, a Canadian contract development and manufacturing organization specializing in chemistry-based services for the production of active pharmaceutical ingredients. Financial details were not disclosed. GL Chemtec operates an innovation center supporting multistep organic synthesis and a new facility comprising a scale-up laboratory and two pilot manufacturing suites, both in Oakville, Ontario.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X